메뉴 건너뛰기




Volumn 11, Issue 3, 2009, Pages 175-186

Analysis of antidepressant prescribing patterns in Italy during years 2001-2005;Analisi della prescrizione di alcuni farmaci antidepressivi in Italia durante il quinquennio 2001-2005

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

EID: 77952904246     PISSN: 15909158     EISSN: 20356137     Source Type: Journal    
DOI: 10.1007/bf03320522     Document Type: Article
Times cited : (2)

References (35)
  • 1
    • 0036803533 scopus 로고    scopus 로고
    • Depression and public health. An overview
    • Cassano P, Fava M. Depression and public health. An overview. J Psychosom Res 2003; 53: 849-857
    • (2003) J Psychosom Res , vol.53 , pp. 849-857
    • Cassano, P.1    Fava, M.2
  • 2
    • 2442569082 scopus 로고    scopus 로고
    • Global burden of depressive disorders in the year 2000
    • Ustun TB, Ayuso-Mateos JL, Chatterji S, et al. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 18: 386-392
    • (2004) Br J Psychiatry , vol.18 , pp. 386-392
    • Ustun, T.B.1    Ayuso-Mateos, J.L.2    Chatterji, S.3
  • 3
    • 19844373148 scopus 로고    scopus 로고
    • Size and burden of mental disorders in Europe: A critical review and appraisal of 27 studies
    • Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357-376
    • (2005) Eur Neuropsychopharmacol , vol.15 , pp. 357-376
    • Wittchen, H.U.1    Jacobi, F.2
  • 6
    • 0032853228 scopus 로고    scopus 로고
    • Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices
    • Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry 1999; 56: 897-904
    • (1999) Arch Gen Psychiatry , vol.56 , pp. 897-904
    • Wells, K.B.1    Sherbourne, C.D.2
  • 7
    • 0028842902 scopus 로고
    • Health-related quality of life in primary care patients with mental disorder: Results from the PRIME-MD Study
    • Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorder: results from the PRIME-MD Study. JAMA 1995; 274: 1511-1517
    • (1995) JAMA , vol.274 , pp. 1511-1517
    • Spitzer, R.L.1    Kroenke, K.2    Linzer, M.3
  • 8
    • 0028799794 scopus 로고
    • Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses
    • Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995; 52: 11-19
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 11-19
    • Hays, R.D.1    Wells, K.B.2    Sherbourne, C.D.3
  • 9
    • 0004152029 scopus 로고    scopus 로고
    • Cassano GB, Pancheri P, Pavan L, et al. (eds). Milano: Masson
    • Cassano GB, Pancheri P, Pavan L, et al. (eds). Trattato Italiano di Psichiatria. Milano: Masson, 2002
    • (2002) Trattato Italiano di Psichiatria
  • 10
    • 0004235298 scopus 로고
    • 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
    • Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994
    • (1994) Diagnostic and Statistical Manual of Mental Disorders
  • 11
    • 0034780546 scopus 로고    scopus 로고
    • Depressive disorders in Europe: Prevalence figures from the ODIN study
    • Ayuso-Mateos JL, Vazquez-Barquero JL, Dowrick C, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001; 179: 308-316
    • (2001) Br J Psychiatry , vol.179 , pp. 308-316
    • Ayuso-Mateos, J.L.1    Vazquez-Barquero, J.L.2    Dowrick, C.3
  • 12
    • 0036331407 scopus 로고    scopus 로고
    • Depression in primary care. A nationwide epidemiological survey
    • Berardi D, Leggieri G, Berti Ceroni G, et al. Depression in primary care. A nationwide epidemiological survey. Fam Pract 2002; 19: 397-400
    • (2002) Fam Pract , vol.19 , pp. 397-400
    • Berardi, D.1    Leggieri, G.2    Berti Ceroni, G.3
  • 13
    • 0029079345 scopus 로고
    • Mechanisms of action of antidepressants
    • Leonard BE. Mechanisms of action of antidepressants. Drugs 1995; 4: 1-12
    • (1995) Drugs , vol.4 , pp. 1-12
    • Leonard, B.E.1
  • 14
    • 0033002399 scopus 로고    scopus 로고
    • Mechanism of action of antidepressant medication
    • Feighner JP. Mechanism of action of antidepressant medication. J Clin Psychiatry 1999; 60: 4-11
    • (1999) J Clin Psychiatry , vol.60 , pp. 4-11
    • Feighner, J.P.1
  • 15
    • 17644423099 scopus 로고    scopus 로고
    • Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
    • Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005; 20: 131-137
    • (2005) Int Clin Psychopharmacol , vol.20 , pp. 131-137
    • Moore, N.1    Verdoux, H.2    Fantino, B.3
  • 16
    • 5444260024 scopus 로고    scopus 로고
    • A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder
    • Bielski RJ, Ventura D, Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychiatry 2004; 65: 1190-1196
    • (2004) J Clin Psychiatry , vol.65 , pp. 1190-1196
    • Bielski, R.J.1    Ventura, D.2    Chang, C.C.3
  • 17
    • 3142756613 scopus 로고    scopus 로고
    • Escitalopram versus Citalopram: The surprising role of the R-enantiomer
    • Sanchez C, Bogeso KP, Ebert B, et al. Escitalopram versus Citalopram: the surprising role of the R-enantiomer. Psychopharmacology (Berl) 2004; 174: 163-176
    • (2004) Psychopharmacology (Berl) , vol.174 , pp. 163-176
    • Sanchez, C.1    Bogeso, K.P.2    Ebert, B.3
  • 18
    • 0036080635 scopus 로고    scopus 로고
    • Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: Pooled analysis of placebo-controlled trials
    • Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr 2002; 7 (4 Suppl. 1): 40-44
    • (2002) CNS Spectr , vol.7 , Issue.4 SUPPL. 1 , pp. 40-44
    • Gorman, J.M.1    Korotzer, A.2    Su, G.3
  • 19
    • 2342481128 scopus 로고    scopus 로고
    • Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder
    • Lepola U, Wade A, Andersen HF. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. Int Clin Psychopharmacol 2004; 19: 149-155
    • (2004) Int Clin Psychopharmacol , vol.19 , pp. 149-155
    • Lepola, U.1    Wade, A.2    Andersen, H.F.3
  • 20
    • 14844365616 scopus 로고    scopus 로고
    • Efficacy of escitalopram in patients with severe depression: A pooled analysis
    • Llorca PM, Azorin JM, Despiegel N, et al. Efficacy of escitalopram in patients with severe depression: a pooled analysis. Int J Clin Pract 2005; 59: 268-275
    • (2005) Int J Clin Pract , vol.59 , pp. 268-275
    • Llorca, P.M.1    Azorin, J.M.2    Despiegel, N.3
  • 21
    • 2642585582 scopus 로고    scopus 로고
    • A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder
    • Montgomery SA, Huusom AK, Bothmer J. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder. Neuropsychobiology 2004; 50: 57-64
    • (2004) Neuropsychobiology , vol.50 , pp. 57-64
    • Montgomery, S.A.1    Huusom, A.K.2    Bothmer, J.3
  • 22
    • 67649231073 scopus 로고    scopus 로고
    • Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram
    • Kasper S, Sacher J, Klein N, et al. Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. Int Clin Psychopharmacology 2009; 24: 119-125
    • (2009) Int Clin Psychopharmacology , vol.24 , pp. 119-125
    • Kasper, S.1    Sacher, J.2    Klein, N.3
  • 23
    • 0038441914 scopus 로고    scopus 로고
    • Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care
    • Lepola UM, Loft H, Reines EH. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003; 18: 211-217
    • (2003) Int Clin Psychopharmacol , vol.18 , pp. 211-217
    • Lepola, U.M.1    Loft, H.2    Reines, E.H.3
  • 24
    • 37349069949 scopus 로고    scopus 로고
    • Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: A six-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients
    • Yevtushenko VY, Belous AI, Yevtushenko YG, et al. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a six-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Clin Ther 2007; 29: 2319-2332
    • (2007) Clin Ther , vol.29 , pp. 2319-2332
    • Yevtushenko, V.Y.1    Belous, A.I.2    Yevtushenko, Y.G.3
  • 25
    • 77952917829 scopus 로고    scopus 로고
    • L'uso dei farmaci in Italia. Rapporto Osmed, Data ultimo accesso Settembre
    • L'uso dei farmaci in Italia. Rapporto Osmed 2005. http://www. agenziafarmaco.it/ATTIVITA-EDITORIALE/gotopage-section3894.html. Data ultimo accesso Settembre 2009
    • (2005)
  • 26
    • 0141998510 scopus 로고    scopus 로고
    • Prevalence estimates of chronic diseases in Italy: Exploring the differences between self-report and primary care databases
    • Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates of chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003; 25: 254-257
    • (2003) J Public Health Med , vol.25 , pp. 254-257
    • Cricelli, C.1    Mazzaglia, G.2    Samani, F.3
  • 27
    • 77952906210 scopus 로고    scopus 로고
    • Use of computerized general practice database for epidemiological studies in Italy: A comparative study with the official national statistics
    • Mazzaglia G, Sessa E, Samani F, et al. Use of computerized general practice database for epidemiological studies in Italy: a comparative study with the official national statistics. J Epidemiol Commun Health 2004; 58 (Suppl. 1): A133
    • (2004) J Epidemiol Commun Health , vol.58 , Issue.SUPPL. 1
    • Mazzaglia, G.1    Sessa, E.2    Samani, F.3
  • 28
    • 0037383191 scopus 로고    scopus 로고
    • Secondary prevention of stroke in Italy: A cross-sectional survey in family practice
    • Filippi A, Bignamini AA, Sessa E, et al. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003; 34: 1010-1014
    • (2003) Stroke , vol.34 , pp. 1010-1014
    • Filippi, A.1    Bignamini, A.A.2    Sessa, E.3
  • 29
    • 0042669800 scopus 로고    scopus 로고
    • Effects of an automated electronic reminder in changing prescribing behaviour among General Practitioners in Italy: An intervention trial
    • Filippi A, Sabatini A, Badioli L, et al. Effects of an automated electronic reminder in changing prescribing behaviour among General Practitioners in Italy: an intervention trial. Diabetes Care 2003; 26: 1497-1500
    • (2003) Diabetes Care , vol.26 , pp. 1497-1500
    • Filippi, A.1    Sabatini, A.2    Badioli, L.3
  • 30
    • 29244462820 scopus 로고    scopus 로고
    • Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care
    • Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093-2100
    • (2005) J Hypertens , vol.23 , pp. 2093-2100
    • Mazzaglia, G.1    Mantovani, L.G.2    Sturkenboom, M.C.3
  • 31
    • 0037237709 scopus 로고    scopus 로고
    • Realta prescrittiva versus standard di consumo nel campo degli inibitori della pompa protonica in Italia
    • Lucioni C, Mazzi S. Realta prescrittiva versus standard di consumo nel campo degli inibitori della pompa protonica in Italia. PharmacoEconomics-Italian Research Articles 2003; 5: 3-10
    • (2003) PharmacoEconomics-Italian Research Articles , vol.5 , pp. 3-10
    • Lucioni, C.1    Mazzi, S.2
  • 32
    • 33751361471 scopus 로고    scopus 로고
    • Resource allocation to brain research in Europe (RABRE)
    • Sobocki P, Lekander I, Berwick S, et al. Resource allocation to brain research in Europe (RABRE). Eur J Neurosci 2006; 24: 2691-2693
    • (2006) Eur J Neurosci , vol.24 , pp. 2691-2693
    • Sobocki, P.1    Lekander, I.2    Berwick, S.3
  • 33
    • 0346622392 scopus 로고    scopus 로고
    • Cost of depression among adults in England in 2000
    • Thomas CM, Morris S. Cost of depression among adults in England in 2000. Br J Psychiatry 2003; 183: 514-519
    • (2003) Br J Psychiatry , vol.183 , pp. 514-519
    • Thomas, C.M.1    Morris, S.2
  • 34
    • 64849100165 scopus 로고    scopus 로고
    • Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States
    • Esposito D, Wahl P, Daniel G, et al. Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clin Ther 2009; 31: 644-656
    • (2009) Clin Ther , vol.31 , pp. 644-656
    • Esposito, D.1    Wahl, P.2    Daniel, G.3
  • 35
    • 67749119872 scopus 로고    scopus 로고
    • Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: A comparison between escitalopram and other SSRI/SNRIs
    • Wu EQ, Greenberg PE, Yang E, et al. Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs. J Med Econ 2009; 12: 124-135
    • (2009) J Med Econ , vol.12 , pp. 124-135
    • Wu, E.Q.1    Greenberg, P.E.2    Yang, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.